Trial to Evaluate the Safety of Lovastatin in Adults With Neurofibromatosis Type I (NF1) - Related Studies

Trial to Evaluate the Safety of Lovastatin in Adults With Neurofibromatosis Type I (NF1)

This study is currently recruiting participants.

Study NCT00352599. Last updated on July 13, 2006. Information provided by University of California, Los Angeles

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neurofibromatosis 1

2	Additional conditions recognized in this trial
		Neurofibromatoses

3	More general conditions related to this trial
		Genetic Diseases, Inborn
		Heredodegenerative Disorders, Nervous System
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Nerve Tissue
		Neoplastic Syndromes, Hereditary
		Nerve Sheath Neoplasms
		Nervous System Diseases
		Neurocutaneous Syndromes
		Neurodegenerative Diseases
		Neurofibroma
		Neuromuscular Diseases
		Peripheral Nervous System Diseases

4	Interventions listed in this trial
		Lovastatin

5	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Enzyme Inhibitors
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		University of California, Los Angeles